FDA inspection
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site): FDA inspection ending Apr 3, 2018
FDA inspection 1048084 · Voluntary Action Indicated (VAI) · Nanjing
Key facts
| Inspection ID | 1048084 |
|---|---|
| Firm | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) |
| FEI number | 3010625707 |
| Address | Nanjing High and New Technology Development Zone, No. 16 XueFu Road |
| City | Nanjing |
| Country | China |
| Fiscal year | 2018 |
| Inspection end date | Apr 3, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data